Nakai Motoki, Sato Morio, Sahara Shinya, Takasaka Isao, Kawai Nobuyuki, Minamiguchi Hiroki, Tanihata Hirohiko, Kimura Masashi, Takeuchi Nozomu
Department of Radiology, Wakayama Medical University, Wakayama-shi, Wakayama, Japan.
Cardiovasc Intervent Radiol. 2009 Jan;32(1):62-9. doi: 10.1007/s00270-008-9462-x. Epub 2008 Nov 6.
Real-time virtual sonography (RVS) is a diagnostic imaging support system, which provides the same cross-sectional multiplanar reconstruction images as ultrasound images on the same monitor screen in real time. The purpose of this study was to evaluate radiofrequency ablation (RFA) assisted by RVS and CT for hepatocellular carcinoma (HCC) undetectable with conventional sonography. Subjects were 20 patients with 20 HCC nodules not detected by conventional sonography but detectable by CT or MRI. All patients had hepatitis C-induced liver cirrhosis; there were 13 males and 7 females aged 55-81 years (mean, 69.3 years). RFA was performed in the CT room, and the tumor was punctured with the assistance of RVS. CT was performed immediately after puncture, and ablation was performed after confirming that the needle had been inserted into the tumor precisely. The mean number of punctures and success rates of the first puncture were evaluated. Treatment effects were evaluated with dynamic CT every 3 months after RFA. RFA was technically feasible and local tumor control was achieved in all patients. The mean number of punctures was 1.1, and the success rate of the first puncture was 90.0%. This method enabled safe ablation without complications. The mean follow-up period was 13.5 month (range, 9-18 months). No local recurrence was observed at the follow-up points. In conclusion, RFA assisted by RVS and CT is a safe and efficacious method of treatment for HCC undetectable by conventional sonography.
实时虚拟超声检查(RVS)是一种诊断成像支持系统,它能在同一监视器屏幕上实时提供与超声图像相同的横断面多平面重建图像。本研究的目的是评估由RVS和CT辅助的射频消融(RFA)对常规超声检查无法检测到的肝细胞癌(HCC)的治疗效果。研究对象为20例患有20个HCC结节的患者,这些结节常规超声检查未检测到,但CT或MRI可检测到。所有患者均为丙型肝炎所致肝硬化;其中男性13例,女性7例,年龄55 - 81岁(平均69.3岁)。RFA在CT室进行,在RVS辅助下对肿瘤进行穿刺。穿刺后立即进行CT检查,确认针已准确插入肿瘤后进行消融。评估首次穿刺的平均次数和成功率。RFA后每3个月用动态CT评估治疗效果。RFA在技术上是可行的,所有患者均实现了局部肿瘤控制。平均穿刺次数为1.1次,首次穿刺成功率为90.0%。该方法能安全消融且无并发症。平均随访期为13.5个月(范围9 - 18个月)。随访时未观察到局部复发。总之,RVS和CT辅助的RFA是治疗常规超声检查无法检测到的HCC的一种安全有效的方法。